Ina Skaara Brorson

Ina Skaara Brorson

Auto-generated profile, based on publicly available information

Ina Skaara Brorson

Oslo University Hospital

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BRBrooke Rhead
Brooke Rhead
IBIna S Brorson
Ina S Brorson
TBTone Berge
Tone Berge
CACameron Adams
Cameron Adams
HQHong Quach
Hong Quach
LBLisa F Barcellos
Lisa F Barcellos
DNA methylation is an epigenetic mark that is influenced by environmental factors and is associated with changes to gene expression and phenotypes. It may link environmental exposures to disease etiology or indicate important gene pathways involved in disease pathogenesis. We identified genomic regions that are differentially methylated in T cells of patients with relapsing remitting multiple sclerosis (MS) compared to healthy controls. DNA methylation was assessed at 450,000 genomic sites in CD4+ and CD8+ T cells purified from peripheral blood of 94 women with MS and 94 healthy women, and differentially methylated regions were identified using bumphunter. Differential DNA methylation was observed near four loci: MOG/ZFP57, HLA-DRB1, NINJ2/LOC100049716, and SLFN12. Increased methylation of the first exon of the SLFN12 gene was observed in both T cell subtypes and remained present after restricting analyses to samples from patients who had never been on treatment or had been off treatment for more than 2.5 years. Genes near the regions of differential methylation in T cells were assessed for differential expression in whole blood samples from a separate population of 1,329 women with MS and 97 healthy women. Gene expression of HLA-DRB1, NINJ2, and SLFN12 was observed to be decreased in whole blood in MS patients compared to controls. We conclude that T cells from MS patients display regions of differential DNA methylation compared to controls, and corresponding gene expression differences are observed in whole blood. Two of the genes that showed both methylation and expression differences, NINJ2 and SLFN12, have not previously been implicated in MS. SLFN12 is a particularly compelling target of further research, as this gene is known to be down-regulated during T cell activation and up-regulated by type I interferons (IFNs), which are used to treat MS.

31 October 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
MAMaren Stolp Andersen
Maren Stolp Andersen
ILIngvild Sørum Leikfoss
Ingvild Sørum Leikfoss
IBIna Skaara Brorson
Ina Skaara Brorson
CCChiara Cappelletti
Chiara Cappelletti
CBConceição Bettencourt
Conceição Bettencourt
LPLasse Pihlstrøm
Lasse Pihlstrøm
Understanding the contribution of immune mechanisms to Parkinson’s disease pathogenesis is an important challenge, potentially of major therapeutic implications. To further elucidate the involvement of peripheral immune cells, we studied epigenome-wide DNA methylation in isolated populations of CD14+ monocytes, CD19+ B cells, CD4+ T cells, and CD8+ T cells from Parkinson’s disease patients and healthy control participants. We included 25 patients with a maximum five years of disease duration and 25 controls, and isolated four immune cell populations from each fresh blood sample. Epigenome-wide DNA methylation profiles were generated from 186 samples using the Illumina MethylationEpic array and association with disease status was tested using linear regression models. We identified six differentially methylated CpGs in CD14+ monocytes and one in CD8 + T cells. Four differentially methylated regions were identified in monocytes, including a region upstream of RAB32, a gene that has been linked to LRRK2. Methylation upstream of RAB32 correlated negatively with mRNA expression, and RAB32 expression was upregulated in Parkinson’s disease both in our samples and in summary statistics from a previous study. Our epigenome-wide association study of early Parkinson’s disease provides evidence for methylation changes across different peripheral immune cell types, highlighting monocytes and the RAB32 locus. The findings were predominantly cell-type-specific, demonstrating the value of isolating purified cell populations for genomic studies.

13 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
RPRafael Riudavets Puig
Rafael Riudavets Puig
IBIna Skaara Brorson
Ina Skaara Brorson
DODenise O’MAhony
Denise O’MAhony
VKVessela Kristensen
Vessela Kristensen
AMAnthony Mathelier
Anthony Mathelier
Transcription is regulated through the sequence-specific binding of transcription factors (TFs) to cis-regulatory regions (CRRs). Although scattered along the genome, multiple CRRs are brought in close spatial proximity to the genes they regulate through the formation of DNA loops. The sequence component of transcriptional regulation suggests that DNA variants in CRRs could disrupt TF-DNA interactions and gene regulatory networks through a cascading effect. To date, only a few cases of recurrent cis-regulatory variants have been described. As an alternative to variant recurrence, some methods utilize genomic annotations that indicate the functional impact (FI) of a variant and the CRRs of each gene to detect the enrichment of high-impact cis-regulatory variants (CRVs). However, the agreement across the different associations and FI scoring methods remains unexplored. This work demonstrates that gene-CRR and FI scoring methods exhibit little consensus, highlighting the impact of the choice of a specific CRR-score combination in a given analysis. In addition, we demonstrate that cancer genes exhibit a higher frequency of FI variants compared to non-cancer genes. Based on this, we developed HiFIseek, a Snakemake pipeline exploring the enrichment of FI variants in associated genomic regions using all region-score combinations and two enrichment detection methods. We apply HiFIseek to detect genes exhibiting high FI CRVs in eight cancer cohorts and a set of breast cancer risk-associated single-nucleotide polymorphisms (SNPs). In the cancer cohorts, we observe a small degree of agreement across CRR-score combinations. Although HiFIseek detected known cancer-related genes with FI CRVs, most of them did not show significant changes in their expression. In the SNPs cohort, HiFIseek found small consensus across CRR-score combinations. However, one of the combinations returned 18 known cancer-related genes, including BRCA1 , showing an enrichment of high-impact CRVs.

6 October 2026 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
RPRafael Riudavets Puig
Rafael Riudavets Puig
DODenise G. O’MAhony
Denise G. O’MAhony
IBIna Skaara Brorson
Ina Skaara Brorson
KSKsenia Sokolova
Ksenia Sokolova
VKVessela Kristensen
Vessela Kristensen
AMAnthony Mathelier
Anthony Mathelier
Transcription is regulated through the sequence-specific binding of transcription factors (TFs) to cis-regulatory regions (CRRs); DNA variants in CRRs can disrupt TF-DNA interactions and gene regulatory networks through a cascading effect. Despite a few cases of reported recurrent cis-regulatory variants (CRVs), another approach for detecting non-coding functional events relies on combining gene-CRR associations capturing the regulatory elements controlling gene transcription, and functional impact (FI) scores quantifying the deleterious effect of variants. While many methods exist for each, how much they agree and how strongly the choice of CRR-FI score combination impacts the prediction of cis-regulatory altered genes has not been systematically assessed. Here, we demonstrate that gene-CRR associations and FI scoring methods exhibit little consensus, highlighting the impact of the choice of a specific CRR-FI score combination in a given analysis. These observations point to the need for a systematic approach to evaluate several gene-CRR and FI scoring methods in a unified framework. To address this gap, we developed HiFIseek, a Snakemake pipeline of two enrichment detection methods exploring the enrichment of high FI variants in CRRs associated with a gene using all region-score combinations. We applied HiFIseek to detect genes exhibiting high functional impact CRVs in eight cancer cohorts and a set of breast cancer risk-associated single-nucleotide polymorphisms (SNPs). We demonstrate that cancer driver genes exhibit a higher frequency of FI CRVs compared to non-cancer genes. In the cancer cohorts, HiFIseek detected genes pointing to cancer-related pathways with enrichment for high FI CRVs despite a small degree of agreement across CRR-FI score combinations. In the SNP cohort, HiFIseek found again small consensus across CRR-score combinations, one of which returned 18 known cancer-related genes, including BRCA1 , showing an enrichment of high-impact CRVs.